3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Breast
1
Conditions
Wounds and Injuries
1
Head and Neck Neoplasms
1
Cancer Pain
1
Breast Neoplasms
1
Interventions
pembrolizumab
2
Cisplatin
2
Boron Neutron Capture Therapy
2
Tranexamic Acid
1
Therapeutics
1
Surgical Procedures, Operative
1
Self Care
1
Radiography, Panoramic
1
Observation
1
Neck Dissection
1
Moxibustion
1
Morphine
1
Magnesium Sulfate
1
Low-Level Light Therapy
1
Lidocaine
1
Hypnosis
1
Gels
1
Gefitinib
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Educational Status
1
DMAC2L protein, human
1
Control Groups
1
Chemoradiotherapy
1
Cetuximab
1
Celecoxib
1
Acupuncture Therapy
1
26S proteasome non-ATPase regulatory subunit 13
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Head and Neck Neoplasms
×
Gels
×
Clear all
NCT05800834
2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2
Unknown
106 enrolled